HALO vs. PNC
Compare and contrast key facts about Halozyme Therapeutics, Inc. (HALO) and The PNC Financial Services Group, Inc. (PNC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HALO or PNC.
Correlation
The correlation between HALO and PNC is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
HALO vs. PNC - Performance Comparison
Key characteristics
HALO:
1.38
PNC:
0.37
HALO:
2.14
PNC:
0.73
HALO:
1.32
PNC:
1.10
HALO:
1.94
PNC:
0.35
HALO:
5.12
PNC:
0.97
HALO:
12.84%
PNC:
10.82%
HALO:
44.71%
PNC:
26.85%
HALO:
-74.26%
PNC:
-76.65%
HALO:
-3.44%
PNC:
-21.00%
Fundamentals
HALO:
$7.56B
PNC:
$65.55B
HALO:
$3.43
PNC:
$14.15
HALO:
17.84
PNC:
11.71
HALO:
-2.50
PNC:
1.71
HALO:
7.38
PNC:
3.12
HALO:
20.78
PNC:
1.16
HALO:
$1.08B
PNC:
$20.90B
HALO:
$887.05M
PNC:
$20.90B
HALO:
$530.80M
PNC:
$75.65B
Returns By Period
In the year-to-date period, HALO achieves a 41.66% return, which is significantly higher than PNC's -11.92% return. Over the past 10 years, HALO has outperformed PNC with an annualized return of 16.03%, while PNC has yielded a comparatively lower 9.36% annualized return.
HALO
41.66%
17.71%
13.55%
61.22%
23.55%
16.03%
PNC
-11.92%
12.49%
-16.41%
9.99%
13.85%
9.36%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HALO vs. PNC — Risk-Adjusted Performance Rank
HALO
PNC
HALO vs. PNC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Halozyme Therapeutics, Inc. (HALO) and The PNC Financial Services Group, Inc. (PNC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HALO vs. PNC - Dividend Comparison
HALO has not paid dividends to shareholders, while PNC's dividend yield for the trailing twelve months is around 3.84%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HALO Halozyme Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PNC The PNC Financial Services Group, Inc. | 3.84% | 3.27% | 3.94% | 3.64% | 2.39% | 3.09% | 2.63% | 2.91% | 1.80% | 1.81% | 2.11% | 2.06% |
Drawdowns
HALO vs. PNC - Drawdown Comparison
The maximum HALO drawdown since its inception was -74.26%, roughly equal to the maximum PNC drawdown of -76.65%. Use the drawdown chart below to compare losses from any high point for HALO and PNC. For additional features, visit the drawdowns tool.
Volatility
HALO vs. PNC - Volatility Comparison
Halozyme Therapeutics, Inc. (HALO) has a higher volatility of 20.47% compared to The PNC Financial Services Group, Inc. (PNC) at 10.39%. This indicates that HALO's price experiences larger fluctuations and is considered to be riskier than PNC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
HALO vs. PNC - Financials Comparison
This section allows you to compare key financial metrics between Halozyme Therapeutics, Inc. and The PNC Financial Services Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HALO vs. PNC - Profitability Comparison
HALO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Halozyme Therapeutics, Inc. reported a gross profit of 216.46M and revenue of 264.86M. Therefore, the gross margin over that period was 81.7%.
PNC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The PNC Financial Services Group, Inc. reported a gross profit of 5.23B and revenue of 5.23B. Therefore, the gross margin over that period was 100.0%.
HALO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Halozyme Therapeutics, Inc. reported an operating income of 141.54M and revenue of 264.86M, resulting in an operating margin of 53.4%.
PNC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The PNC Financial Services Group, Inc. reported an operating income of 2.63B and revenue of 5.23B, resulting in an operating margin of 50.2%.
HALO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Halozyme Therapeutics, Inc. reported a net income of 118.10M and revenue of 264.86M, resulting in a net margin of 44.6%.
PNC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The PNC Financial Services Group, Inc. reported a net income of 1.48B and revenue of 5.23B, resulting in a net margin of 28.3%.